China Resources Double-Crane Pharmaceutical financials at a glance

Year Year 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Rev. Revenue
¥1.10B ¥4.60B ¥4.13B ¥4.56B ¥4.95B ¥5.04B ¥5.37B ¥6.38B ¥6.99B ¥6.83B ¥5.15B ¥5.14B ¥5.49B ¥6.42B ¥8.23B ¥9.38B ¥8.50B ¥9.11B ¥9.45B ¥10.22B ¥0.00M
GM % Gross Margin %
51.13% 26.81% 28.12% 29.95% 30.80% 33.81% 35.69% 32.17% 33.13% 34.44% 51.00% 51.38% 52.76% 57.20% 63.20% 63.22% 62.87% 55.57% 55.01% 54.93% 0.00%
OM Operating Margin
11.56% 4.97% 5.49% 9.24% 8.95% 10.70% 10.85% 10.09% 9.74% 11.36% 15.92% 14.02% 15.28% 15.83% 13.69% 13.12% 13.80% 11.35% 12.89% 14.44% 0.00%
EPS Earnings Per Share
¥0.24 ¥0.18 ¥0.36 ¥0.42 ¥0.53 ¥0.56 ¥0.58 ¥0.66 ¥0.75 ¥0.63 ¥0.49 ¥0.63 ¥0.78 ¥0.87 ¥0.95 ¥0.92 ¥0.00
Div. Dividends
¥0.00 ¥0.00 ¥0.09 ¥0.11 ¥0.08 ¥0.00 ¥0.16 ¥0.27 ¥0.22 ¥0.24 ¥0.00 ¥0.13 ¥0.07 ¥0.08 ¥0.28 ¥0.30 ¥0.29 ¥0.00 ¥0.00 ¥0.26 ¥0.00
PR % Payout Ratio %
0 0 50.00% 30.56% 19.05% 0 28.57% 46.55% 33.33% 32.00% 0.00% 26.53% 11.11% 10.26% 32.18% 31.58% 31.52% 0 0 0 0
Sha. Shares
762.18m 762.18m 762.18m 762.18m 823.24m 823.24m 823.24m 823.24m 823.24m 823.24m 823.24m 1043.24m 1043.24m 1043.24m 1043.24m 1043.24m 1043.24m 1043.24m 1021.57m 0m 1020.98m
OCF Operating Cash Flow
¥453.72M ¥0.00M ¥303.62M ¥235.46M ¥331.71M ¥342.01M ¥561.40M ¥511.53M ¥396.05M ¥546.24M ¥928.91M ¥701.35M ¥771.25M ¥1.19B ¥1.47B ¥1.44B ¥1.36B ¥1.34B ¥1.34B ¥1.63B ¥0.00M
FCF Free Cash Flow
¥256.88M ¥0.00M ¥131.92M ¥99.29M ¥165.26M ¥56.85M ¥196.78M ¥172.75M ¥186.64M ¥447.52M ¥796.18M ¥546.70M ¥662.42M ¥1.04B ¥1.24B ¥1.20B ¥1.05B ¥849.25M ¥816.14M ¥1.02B ¥0.00M
FCFS Free Cash Flow Per Share
¥0.34 ¥0.00 ¥0.17 ¥0.13 ¥0.03 ¥0.07 ¥0.23 ¥0.21 ¥0.21 ¥0.40 ¥0.73 ¥0.51 ¥0.63 ¥0.99 ¥1.19 ¥1.15 ¥0.97 ¥0.81 ¥0.79 ¥1.00 ¥0.00